Journal of the Minnesota Academy of Science
Volume 53

Number 1

Article 6

1987

Perspectives on Biotechnology Development in Minnesota
Michael C. Flickinger
University of Minnesota

Follow this and additional works at: https://digitalcommons.morris.umn.edu/jmas
Part of the Biotechnology Commons

Recommended Citation
Flickinger, M. C. (1987). Perspectives on Biotechnology Development in Minnesota. Journal of the
Minnesota Academy of Science, Vol. 53 No.1, 21-25.
Retrieved from https://digitalcommons.morris.umn.edu/jmas/vol53/iss1/6

This Article is brought to you for free and open access by the Journals at University of Minnesota Morris Digital
Well. It has been accepted for inclusion in Journal of the Minnesota Academy of Science by an authorized editor of
University of Minnesota Morris Digital Well. For more information, please contact skulann@morris.umn.edu.

Perspectives on Biotechnology Development
in Minnesota
MICHAEL C. FLICKINGER

Michael C. Flickinger is Associate Professor of Biochemistry and Director of the Institute
for Advanced Studies in Biological Process Technology at the University of Minnesota.

Minnesota's Strengths
The biotechnology industry in Minnesota can be broadly
defined as including biomedical device firms, biological
engineering firms, industries that produce research or manufacturing equipment for biotechnology or treatment of process wastes, and industries that provide fermentation substrates. This definition of biotechnology-related industries is
significantly different than in other states where the focus of
biotechnology-related research and development is primarily
in major pharmaceutical and chemical manufacturing firms.
In general, Minnesota has a strong entrepreneurial emphasis for promoting new industries, relatively low unemployment, and an excellent educational system. However, Minnesota has not recognized the potential for positive economic
development, specifically for attracting new firms related to
biotechnology, as have many other states. Over the last four
years, states such as North Carolina, Delaware, New Jersey,
Colorado, Michigan, Massachusetts, Maryland, Pennsylvania,
Tennessee, Virginia, New York, and California have encouraged biotechnology by marketing their states' educational,
business, and high technology resources to investors and
entrepreneurs. These states have specifically sought to attract
biotechnology firms and to coordinate research in progress in
academic institutions, the private sector, and at federal laboratories located within their states. Particularly good examples
of effective promotional information are the publication
"Techne" by the North Carolina Biotechnology Center ancf the
Colorado Bio-Industrial]ournal ( 1), which recently reported
on the number ofbio-industrial companies founded in Colorado since 1968 (Figure 1).
Minnesota has only recently developed similar comprehensive plans for attracting biotechnology industries. In 1985
the Governor created a task force to decide on the most
appropriate direction for educational and business development to attract biotechnology-related industry to Minnesota
(2 ). From this task force report, a state Biotechnology Council
was formed, led by industry and higher education, which has
recently published an extensive plan for biotechnology
development ( 3). One key component of this plan is a survey
of the potential economic impact of biotechnology on the
state ( 4 ). This recent economic analysis projects that 20,000 to
68,000 new jobs could occur as the result of development of
new industries in biotechnology by the year 2000 (Figure 2 ).
These projections may be conservative. The basis for this
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projection included 100 established firms in Minnesota
related to biotechnology, with a current employment of9,000
individuals (Table 1). The analysis did not include expansion
of existing significant biotechnology research groups in
related industries.
Table 1. Calculation of Minnesota 1985 "base-year" employment in
the biotechnology industry ( 4).
Biomedical Biological
Devices
Engineering
Number of Firms
Meeting Definition

83

11

Number for which Employment
Was Found

69

8

8,424

308

Firms for which Employment
Figures Missing

14

3

Values Used Per Firm for
Missing Employment Figures

15

10

210

30

Total Employees (subtotal
plus additional)

8,634

338

Figure Used for Projection
(rounded)

8,650

350

Identified Employment

Additional Employment Assumed

The major components of Minnesota's strength in biotechnology development are the breadth and quality of the University of Minnesota biological, engineering, biomedical,
agricultural, and dairy research programs, which rank among
the highest in the nation in terms of funded research (5).
These programs have been augmented by a baccalaureate
biotechnology interdisciplinary degree program in the State
Universiry system, which includes a program for introducing
high school science teachers to basic methods in biotechnology (3).

Major Constraints
Even though a statewide plan developed by industry, state
government, and the academic institutions exists (3) , two
21
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Figure 1. Biotechnology company foundings and employment in
Colorado since 1968 (1 ).

from basic research in academic institutions: universityuniversity communication, university-industry communication, and the developing industries' ability to effectively
communicate with state government. Ifbiotechnology specifically is to be fostered, then these communication constraints
need to be considered carefully before major decisions or
programs are created.
Widely promoted is the concept of technology transfer
between the university community and industry. However,
before questioning whether this can be fostered, it is important to consider communication among faculty at the same
academic institution and between academic institutions .
Past experience indicates that communication among
faculty at the same institution is often less than optimal. The
organization and coordination offacultywithin a discipline is
often difficult-much less between disciplinary areas. Communication between academic institutions is hindered and
actually discouraged due to the traditional mechanisms of
competitive grant support from federal or industrial sources.
With respect to biotechnology as a specific new industry
and the proprietary constraints dictated by current patent law,
additional professional and ethical guidelines often need to
be developed to insure separation of academic and business
interests for faculty that teach and supervise students while
consulting or actively participating in the creation of new
start-up industries. This question of limited communication
between industry researchers and academic scientists has
often been debated with regard to the potential negative
effects it may have through limiting academic freedom.
Recent evidence suggests that funding of academic research
by industry over the past two decades has not resulted in
significant compromises of the freedom of the researchers to
train students and publish their results ( 6).
Academic faculty in related fields can interact with industry
by a variety of mechanisms: on a one-to-one basis or as groups
of faculty in a cooperative or consortium agreement (Table 2 ).

Table 2. University- Industry Interactions.

constraints must be overcome if development of a more active
biotechnology-related state industry is to occur. These constraints are 1) ineffective two-way communication between
faculty associated with basic research and scientists in firms
interested in applications ofthese results ; and 2) the present
minimal coordination among faculty and among academic
institutions resulting in duplication of research and educational programs.
A variety of techniques exist for the transfer of genes into
appropriate vectors and host organisms for expression and
subsequent scale-up to manufacture of large quantities of
diagnostic or therapeutic proteins, drugs, enzymes, and biopolymers for industry. Much of this technology is poorly
protected by traditional process patent or new-compositionof- matter patent law. Consequently, for competing firms to
maintain a competitive technology, research and development must remain trade secrets. This results in major communication restraints between industries and between indus·
try and academic laboratories unless specific proprietary
agreements are negotiated with each faculty laboratory to
limit the dissemination of research results prior to publication
or patent disclosure.

Communication
Communication problems in three areas exist that have in
the past constrained development of new industries created
22

Communication
• One-on-one
-consultant
-seminars
-conferences

• Cooperative
-sponsored
research
-licensing
-sharing personnel,
facilities
-internships
-consortium

Advantages

Disadvantages

-specific
-timely
-maintain
proprietary
interest

-limited scope ·
-not generic
-limited participants

-cost benefits
-risk minimized
-timely

-singular solutions
-not long lasting
-cannot maintain
proprietary position

The one-to-one relationship between faculty and industry
will always exist. This is a rapid way for industry to address
specific questions. It can be done efficiently by faculty giving
seminars or conferences, and faculty acting as individual consultants. Proprietary interests can be maintained because the
relationship is limited in scope. This type of interaction, however, involves a limited number of participants, is not generic,
and usually does not lead to development of major new
industries.
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Figure 2. Projected Minnesota employment in the biotechnology industry. ( 4).

Coordination

Cooperative agreements among faculty and with more than
one industty are being actively fostered by federal research
programs such as the Industty/University Cooperative Research Centers program of the National Science Foundation
(NSF) (Table 3) (6). This program has created national Genters for consortia of companies and large numbers of participating faculty. These types of interactions differ from the
one-on-one faculty-industty interactions in that a large
number of faculty are involved and more than one industty is
participating. Firms in this program may sponsor research that
crosses disciplinaty lines and involves faculty from a variety of
traditional academic departments. The participating firms may
have the opportunity to negotiate with the university for
reduction in indirect costs, licensing, acquisition of particular
technologies and patenting of research results in order to
create incentives for sponsoring research in an academic
environment as opposed to within their own firms. There may
also be sharing of personnel and facilities between the university and participating industries in these centers or consortia.
The students participating in these activities may obtain beneficial exposure to the significant problems in the participating
industries or even work in industrial research laboratories as
part of their educational experience.
Volume 53, Number 1, 1987/88

Table 3. The role of university/industry consortia in biotechnology
development.
•
•
•
•

•
•
•
•
•
•

Forum for exchange
Collaborative projects
Provides industry-industry exchange
Two-way internships
-personnel
-lectures, seminars, courses
-facility sharing
Industrial advisory roles
Leveraged R&D expenditures
Right of first refusal
Recruitment
Faculty insights to industry
"Beta" site at university

In biotechnology-related disciplines, however, these research consortia are difficult to foster because of the proprietaty nature of the research. Consortia by definition have to
pool resources to address common or generic questions to
the benefit to all sponsoring organizations. This significantly
leverages each participating firm's investment as well as minimizes the risks. Because of the mechanism of pooling of
resources, however, it is less likely that this type of research
will be related to a specific product for a specific firm.
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It is unfortunate that among the 39 NSF centers specifically
designed to foster industry/ university cooperative research,
only two directly related to biotechnology have been supported by industry. These are the Monoclonal Antibody Lymphocyte Engineering Research Center in North Carolina and
the Center for Biocatalytic Processing in Minnesota.
In addition to the Industry/ University Cooperative Research
Programs, the NSF has also created Engineering Research
Centers (ERCs) as an additional mechanism to develop
university-industry collaborative consortia (6). One ERC
directly related to biotechnology is the Massachusetts Institute
ofTechnology's Engineering Research Center in Biochemical
Process Engineering, which has a five-year, $20 million grant
from NSF with active financial participation from biotechnology-related industries. In this case, a major commitment
was required by the academic institution in terms of space,
administrative staff, industrial liaison staff, and patent office
staff to coordinate the center. The annual operating overhead
expenditure for the administration of this large corsortia is
$200,000-$300,000. This cost does not include the space
required by visiting industrial scientists and new equipment
specifically for the center use. Nor does this figure reflect the
amount of time required by the faculty involved, not only for
the research but to effectively interact with the large number
of participating firms by presenting research reports at annual
center meetings, entertaining visiting scientists from industry,
and acting as individual consultants to the member firms.
The commitment of faculty time is, in many cases, the
greatest restraint. These collaborative and consortia activities
compete with faculty teaching time and the time required for
faculty to effectively recruit and train graduate students.
Faculty members continue, as they always have in the past, to
be primarily interested in scholarly publication and teaching,
which lead to their ability to attain tenure and be promoted.
Unless academic-industrial interactions are recognized and
fostered by the promotion and tenure process, as they are at a
small number of technological institutions in this country and
more extensively in foreign countries, there will continue to
be little incentive for many faculty to participate in view of
their other time commitments.
Some institutions have created centers or industries known
as organized research units ( ORUs) to address these interdisciplinary administrative, space, and time commitment problems (7). In some instances, collaboration has been fostered
by releasing faculty from teaching and university service
responsibilities. If not monitored closely by the institution,
this may contribute to inequities among faculty and further
discourage faculty participation.

Creation of Incentives
Many firms in advanced technologies have traditionally
sought to leverage their abilities by locating themselves near
academic institutions. The objective is to foster translation of
developing technologies from an academic, basic research
environment into the developing new industry.
Implicit in this assumption is that there are few communication constraints between the academic and private sector
institutions. How realistic is this assumption for biotechnology and should Minnesota emphasize this similar approach
for development of new biotechnology industries?
State Promotion
Many states are seeking to promote biotechnology-related
industries in spite of the proprietary nature ofthis technology
by promoting evidence of existing collaborations between
24

academic and private researchers. The state of Texas, for
example, has structured an approach where the major fraction
of biotechnology-related new research funds could come
from the private sector through the Dallas Biotechnology
Development Corp. (8). Other states have created similar
mechanisms, primarily using private or state funds derived
from a major existing state industry to attempt to stimulate
translation of biotechnology research into industrial results.
Some states have chosen to foster communication by creation of industrial parks specifically tailored in their design and
facilities for biotechnology industry. One example of this is
the Massachusetts Biotechnology Research Park (9) , which is
located adjacent to 10 educational institutions with specific
business incubator facilities for biotechnology-related industry. Table 4 summarizes the time lag from creation of the
Worcester Biotechnology Development Corp.(WBDC) to the
actual beginning of construction of facilities (9). This example. emphasizes the legislative milestones, enabling legislation, tax incentives, and zoning, which had to be created prior
to actually building and attracting tenants.
Table 4. Milestones in the development of the Massachusetts Biotechnology Research Park. (MBRP)
• WBDC First to Propose a Biotechnology Complex on 75 acres on Plantation Street in Worcester
• Land Declared Surplus by the Board of Trustees of the University of Massachusetts
• Deadline for Developers' Proposals for Use of
Plantation Street Land
• WBDC Awarded Development of Park by
Governor Michael S. Dukakis
• Enabling Legislation Passed
• Scientific Director Appointed
• Cooperation Between the WBDCand the University of Massachusetts Medical Center
Established
• Sasaki Associates Selected as the Design Firm
• Environmental Impact Report Process
Initiated
• Massachusetts Biotechnology Research Institute Incorporated
• Title to Land Conveyed by State
• City Zoning Ordinance Approved
• City Biomedical Research Ordinance
Approved
• Title Insurance Obtained
• Project Director Appointed
• Bill Creating Center of Excellence in Biotech
Park Signed by Governor
• Final Environmental Impact Report Certified
by Massachusetts Secretary of Environmental Affairs
• Hines Industrial named developer for MBRP

1981

May 1982
November 1982
April 1983
July 1983
July 1983
August 1983

October 1983
February 1984
April 1984
June 1984
July 1984
August 1984
September 1984
January 1985
January 1985
March 1985

April 1985

Recently, the city of Minneapolis and the University of
Minnesota have rekindled development of a similar high
technology park to be located next to the University as a
potential lure to attract new high technology industry (10).
Current tenants in this development include the University's
Supercomputer Institute and firms that will benefit from
access to this facility. In the future , however, this development
could also be tailored to attract biotechnology-related industries. A similar 110-acre Minnesota Medical Enterprise Park
devoted exclusively to medical technology is being developed in Coon Rapids (11).
Journal of th e Minnesota Academy of Science

Industry- University Communication
Physical proximity of these developing industries to academic institutions alone, however, does not insure effective
communication between academic and industrial researchers.
Effective avenues of communication in Minnesota need to
be opened so that industry-university communication is not a
one-way street. Developing industries seeking collaborations
with academic scientists require mechanisms not only to find
faculty involved in related basic research but also to protect
disclosure of their needs and plans. This is the primary problem in development of a biotechnology industry-complete
disclosure is seldom possible due to the proprietary nature of
the developing technology.
The fostering of industry-university communication could
also be stimulated by distribution to industry of information
concerning faculty research interests and expertise. Where
does a new company go when it wants to find this basic
information? Simply listing faculty research interests will not
indicate to firms which faculty have any interest in or perception of the significant technological hurdles for development
of new industries.

Overcoming Constraints in Minnesota
Table 5 summarizes the active participation required by
industry, state government, and academic institutions in order
to overcome communication and coordination constraints
and enhance university-industry interactions in Minnesota in
biotechnology. Primary considerations must be to coordinate
efforts among academic institutions, avoid duplication, and at
the same time promote communication between industrial
and academic scientists (Table 6).
Table 5. Commitments needed by state industry and government to
foster biotechnology development.
•

Industry must demand active participation and financial support from state government for:
1. Training programs for workforce
2. Long term high quality research and facilities for
research
3. Mechanisms to reward participation by faculty in both
basic and applied research

•

Industry must work with State government to revise the business climate for both biotechnology start-ups and expansions.

•

Government and industry must promote Minnesota as a
coordinated biotechnology climate with existing educational
progrnms.
•

Effective and equitable mechanisms must be explored to
reward faculty for participation in research and industrial
collaborations to foster state industry. This reward mechanism
must be factored into the regular promotion and tenure pro-
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Table 6. Methods to enhance university-industry interactions in
Minnesota.
•

Develop university, private colleges, AVTI consortia
- Sharing of personnel, facilities, students

•

Method of faculty reward for participation
- Contribution to tenure, promotion decisions
- High standard of quality in both research and teaching

•

Clear definition to state industry of educational resources
- What talent exists and where
-Specific interests of individual universities
- Geographic distribution within the state

cess in such a way to sustain only the highest standard of
teaching and research. The experience of other states has
shown that in order to foster new industry, academic institutions must contribute the highest quality and most innovative
research and teaching programs, which can be coordinated
with a business environment that promotes rapid development and translation of the results of basic research into new
ventures.
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